XORTX Therapeutics Inc. (NASDAQ:XRTX) Short Interest Update

XORTX Therapeutics Inc. (NASDAQ:XRTXGet Free Report) was the target of a significant growth in short interest during the month of April. As of April 30th, there was short interest totaling 79,644 shares, a growth of 79.0% from the April 15th total of 44,502 shares. Based on an average daily trading volume, of 6,498,507 shares, the short-interest ratio is currently 0.0 days. Approximately 6.1% of the company’s shares are sold short.

Institutional Investors Weigh In On XORTX Therapeutics

A hedge fund recently bought a new stake in XORTX Therapeutics stock. DRW Securities LLC acquired a new position in XORTX Therapeutics Inc. (NASDAQ:XRTXFree Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 193,599 shares of the technology company’s stock, valued at approximately $109,000. DRW Securities LLC owned approximately 2.78% of XORTX Therapeutics as of its most recent filing with the Securities and Exchange Commission. 0.23% of the stock is owned by hedge funds and other institutional investors.

XORTX Therapeutics Price Performance

Shares of NASDAQ XRTX opened at $2.60 on Tuesday. The stock has a market capitalization of $4.03 million, a P/E ratio of -0.87 and a beta of 0.80. The company has a 50-day moving average price of $2.33 and a 200-day moving average price of $2.60. XORTX Therapeutics has a 1 year low of $1.73 and a 1 year high of $7.05.

XORTX Therapeutics (NASDAQ:XRTXGet Free Report) last issued its quarterly earnings data on Thursday, February 26th. The technology company reported ($0.45) earnings per share (EPS) for the quarter.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of XORTX Therapeutics in a report on Friday, March 27th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, XORTX Therapeutics has a consensus rating of “Sell”.

Get Our Latest Stock Analysis on XRTX

About XORTX Therapeutics

(Get Free Report)

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers.

Further Reading

Receive News & Ratings for XORTX Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XORTX Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.